Lv5
980 积分 2023-04-21 加入
T Cell Costimulation with Anti-CD137 Monoclonal Antibodies Is Mediated by K63–Polyubiquitin-Dependent Signals from Endosomes
1个月前
已完结
Costimulatory capacity of CD137 mAbs on T cells depends on elaborate CRD structures but not on blocking ligand‒receptor binding
1个月前
已完结
4-1BB Ligand Signaling to T Cells Limits T Cell Activation
1个月前
已完结
Human/mouse CD137 agonist, JNU-0921, effectively shrinks tumors through enhancing the cytotoxicity of CD8 + T cells in cis and in trans
1个月前
已完结
TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhausted T cell proliferation and terminal differentiation
1个月前
已完结
Safety, Feasibility, and Pharmacodynamic Activity of Intratumoral Injections of the Agonist Anti-CD137 (4-1BB) mAb Urelumab in Combination with Nivolumab
1个月前
已完结
Antibody-Mediated Delivery of BRM/BRG1 Protein Degraders Affords Strong Antitumor Efficacy in Multiple BRM-Dependent Non-Small Cell Lung Cancer Xenograft Models
1个月前
已完结
Realizing the potential of agonistic antibody immunotherapy
2个月前
已完结
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
2个月前
已完结
CD137-Mediated Pathogenesis from Chronic Hepatitis to Hepatocellular Carcinoma in Hepatitis B Virus-Transgenic Mice
2个月前
已完结
皖公网安备34019202002308
